5 news items
Annexon Announces Pricing of $125 Million Underwritten Public Offering
ANNX
5 Jun 24
-looking statements that the company makes in this press release are made pursuant to the Private Securities Litigation Reform Act of 1995, as amended
Annexon Announces Proposed Public Offering of Common Stock
ANNX
4 Jun 24
Litigation Reform Act of 1995, as amended, and speak only as of the date of this press release. Except as required by law, the company undertakes
Annexon Presents New Neuroprotection Data Showing ANX007 Protects Vision and Vision-Associated Structures in Geographic Atrophy at ARVO 2024 Annual Meeting
ANNX
7 May 24
release are made pursuant to the Private Securities Litigation Reform Act of 1995, as amended, and speak only as of the date of this press release
Annexon to Present Data Reinforcing the Neuroprotective Effects of ANX007 and C1q Inhibition in Geographic Atrophy at the ARVO 2024 Annual Meeting
ANNX
1 May 24
are made pursuant to the Private Securities Litigation Reform Act of 1995, as amended, and speak only as of the date of this press release. Except
Annexon Reports Fourth Quarter and Year-End 2023 Financial Results and Key Anticipated Milestones
ANNX
26 Mar 24
forward-looking statements that the company makes in this press release are made pursuant to the Private Securities Litigation Reform Act of 1995
- Prev
- 1
- Next